Home

OPEN YOUR IDEA, INNOVATE LIFE with DAEWOONG

Your ideas become innovation when they meet Daewoong.

Today, success in the pharmaceutical industry is no longer possible through internal capabilities alone.
Daewoong Pharmaceutical has made open collaboration one of its core growth engines,
actively working with top experts and partners in Korea and around the world.

We welcome universities, biotechs, startups, and researchers at home and abroad
who have innovative ideas and technologies.

Join Daewoong Pharmaceutical in developing global innovative medicines that improve quality of life,
and be part of the journey to share in that success.

Please share your ideas.


Daewoong Pharmaceutical turns them into reality.

Daewoong Open Collaboration Benefits

Daewoong Pharmaceutical collaborates with promising partners through its differentiated pharmaceutical and biotech collaboration programs and customized package programs tailored to each startup stage.

01 Acceleration programs by company growth stage

Startup investment
Startup investment

Startup support, seed investment support, investment linked to the Southeastern New Deal Fund

Global network
Global network

Global expansion consulting through a bio global network (e.g., Harbour BioMed, Roivant) and a network of 10 overseas branches

Infrastructure support
Infrastructure support

Daewoong Open-LABs in Yongin and Gyeongnam, as well as smart office spaces in Samseong-dong, Hangang ferry terminal, Yongin, and Magok.

Joint research
Joint research

growth factor and stem cell-based nonclinical/clinical candidate libraries

Diverse business models
Diverse business models

JV formation, research institute spin-offs, in-house venture establishment, strategic follow-on investment, and manufacturing/marketing partnerships

  • Startup investment
    Startup investment

    Startup support, seed investment support, investment linked to the Southeastern New Deal Fund

  • Global network
    Global network

    Global expansion consulting through a bio global network (e.g., Harbour BioMed, Roivant) and a network of 10 overseas branches

  • Infrastructure support
    Infrastructure support

    Daewoong Open-LABs in Yongin and Gyeongnam, as well as smart office spaces in Samseong-dong, Hangang ferry terminal, Yongin, and Magok.

  • Joint research
    Joint research

    growth factor and stem cell-based nonclinical/clinical candidate libraries

  • Diverse business models
    Diverse business models

    JV formation, research institute spin-offs, in-house venture establishment, strategic follow-on investment, and manufacturing/marketing partnerships

02 Daewoong Pharmaceutical’s Venture Incubation Program: INNOBEAR Competition

Your ideas become reality with INNOBEAR!

The INNOBEAR Competition is a practical win-win program that identifies promising partners at an early stage and
turns their ideas into real innovative new drugs through the strong support of the Daewoong Group.
Through this competition each year, Daewoong supports promising pre-entrepreneurs, early-stage TIPS investment,
and follow-up acceleration.

Open Collaboration Status

Daewoong is creating innovations for human health together with partners with expertise in diverse fields.

  • logo-1
  • logo-2
  • logo-3
  • logo-4
  • logo-5
  • logo-6
  • logo-7
  • logo-8
  • logo-9
  • logo-10
  • logo-11
  • logo-12
  • logo-13
  • logo-14
  • logo-15
  • logo-16
  • logo-17
  • logo-18
  • logo-19
  • logo-20
  • logo-21
  • logo-22
  • logo-23
  • logo-24
  • logo-25
  • logo-26
  • logo-27
  • logo-28
  • logo-29
  • logo-30
  • logo-31
  • logo-32
  • logo-33
  • logo-34

Collaboration Cases

R&D·Tech | DAEWOONG